A randomized, double‐blind, placebo‐controlled trial of abatacept for the treatment of relapsing, non‐severe, granulomatosis with polyangiitis

Journal:
Arthritis & Rheumatology
Published:
DOI:
10.1002/art.43272
Affiliations:
26
Authors:
31
Institutions Authors Share
University of South Florida (USF), United States of America (USA)
4.000000
0.13
University of Pennsylvania (Penn), United States of America (USA)
3.000000
0.10
Mayo Clinic, United States of America (USA)
2.000000
0.07
University of Cambridge, United Kingdom (UK)
2.000000
0.07
Cleveland Clinic, United States of America (USA)
2.000000
0.07
Boston University (BU), United States of America (USA)
1.000000
0.03
Mount Sinai Hospital (MSH), U of T, Canada
1.000000
0.03
University of Alberta (U of A), Canada
1.000000
0.03
University of Michigan (U-M), United States of America (USA)
1.000000
0.03
Hospital for Special Surgery (HSS), United States of America (USA)
1.000000
0.03
University of Pittsburgh (Pitt), United States of America (USA)
1.000000
0.03
University of Calgary (U of C), Canada
1.000000
0.03
Royal Berkshire Hospital, Royal Berkshire NHS Foundation Trust, United Kingdom (UK)
1.000000
0.03
University of Kansas Medical Center (KUMC), United States of America (USA)
1.000000
0.03
St. Vincent's University Hospital, Ireland
1.000000
0.03
Nottingham University Hospitals NHS Trust (NUH), United Kingdom (UK)
1.000000
0.03
Cedars-Sinai Medical Center (Cedars-Sinai), United States of America (USA)
1.000000
0.03
The University of Utah (Utah), United States of America (USA)
1.000000
0.03
Oregon Health and Science University (OHSU), United States of America (USA)
1.000000
0.03
St. Joseph's Healthcare Hamilton (SJHH), HHS, Canada
0.500000
0.02
McMaster University, Canada
0.500000
0.02
St. Paul's Hospital, Canada
0.500000
0.02
The University of British Columbia (UBC), Canada
0.500000
0.02
Medius KLINIKEN gemeinnutzige GmbH, Germany
0.500000
0.02
University of Tübingen (Uni Tübingen), Germany
0.500000
0.02